PNOC co-Founder and co-Leader, Dr. Michael Prados, and PNOC Scientific Chair, Dr. Adam Resnick, " share important developments in pediatric cancer research and also a potential shift in the way research is conducted, and funded, particularly with regard to a novel NIH/NCI SPORE grant," as reported by Jack's Angels Foundation (https://jacksangelsfoundation.com/?p=6847). Amanda Haddock of DragonMaster Foundation joined the discussion in the second half to speak to the data resources and the sharing capabilities of Cavatica, a cloud-based environment for securely storing, sharing and analyzing large volumes of pediatric brain tumor genomics data.
The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is an international consortium with study sites within the United States, Canada, Europe and Australia. We are dedicated to bringing new therapies to children and young adults with brain tumors. Our goal is to improve outcomes by translating the latest findings in brain tumor biology into better treatments for these children.
Patients with brain tumors that cannot be treated with standard therapy, or that have recurred following standard therapy, are often eligible for clinical trials. Clinical trials provide access to promising new treatments that may not be available outside specialized centers.
At PNOC, our focus is personalized medicine – testing new therapies that are specific to the biology of each patient’s tumor to maximize their effectiveness. Our goal is to improve overall outcome for children with brain tumors.